We are excited to announce that BPSGHAN and BAPEN are jointly hosting the Intestinal Failure Networking Day in Newcastle on Monday 4th November 2024. This event is designed to improve knowledge and skills in the management of complex nutrition and intestinal failure (IF) in children, targeting consultants, trainees, and allied healthcare professionals.
We are delighted to be joined by an impressive line-up of speakers from different centres. The programme features a blend of practical management strategies and showcases current research into genomics and the gut microbiome in intestinal failure and the day will conclude with a joint session with BAPEN Medical, discussing topics of shared interest.
Registration Fee from £10.00 per member trainee including refreshments, lunch and VAT.
We also encourage trainees and others to submit their abstracts for oral or poster presentations. Deadline for submissions: 15thSeptember 2024.
20 Travel Bursaries up to £100 are available for Trainees and AHP’s on a first come first served basis to apply please complete the online form.
Note:
Travel Bursaries are only available to Trainee and AHP BSPGHAN members who register for the IF Networking Day on Monday 4thNovember and proof of registration will be required if the application is successful.
Travel will be reimbursed after the event on completion of the Claims Form with appropriate receipts.
Transforming the care of patients with complex inflammatory bowel disease.
Genomic analysis is a foundation of precision medicine. With a better understanding of the molecular causes of inflammatory bowel diseases (IBD) and enteropathies there are therapeutic opportunities. Increasingly there is realisation of a spectrum of disease where multifactorial and polygenic Crohn’s disease, ulcerative colitis, and IBD unclassified, is complemented by monogenic conditions that can present with intestinal inflammation. For those exceptionally rare monogenic conditions, the NHS has commissioned genomic testing. The diagnostic challenge is to select those patients who might benefit from genomic medicine, to interpret the genetic results, validate the findings and select evidence-based treatments.The successful implementation and progression of clinical genomics requires multi-disciplinary care, specialist knowledge and establishment of professional networks. The monogenic IBD grand round series, aims to discuss diagnostics and clinical care for patients with suspected or confirmed monogenic IBD supporting practical implementation of clinical genomics in paediatric and adult IBD.
Aim is to discuss genetics, immunology, endoscopy, histology, and treatment of complex patients challenging mIBD patients where a clear learning objective is achieved or a national specialist input might be helpful (England, Scotland, Wales, NI). Themonogenic IBD grand round is a clinical and educational forum to bridge and support ongoing multi-disciplinary care discussions and specialised clinics in each region.
Audience: Paediatric and adult gastroenterologists, immunologists, geneticists, SHO and registrars / trainees.
Name of the presenter and co-presenter and hospital:
Patient history background (all strictly anonymised)
Patient phenotype (including age of IBD onset, extraintestinal manifestations, previous/current treatments):
Family history: Genetic investigations and genotype: Immunological tests and key results: Discussion, recommendation for patient care and key questions:
3-4 presentations will be selected. This is an opportunity to present for trainees and receive mentoring from specialists in the field.
An exciting 2 day hands on, interactive motility course at Evelina Hospital will be held on 11-12 July 2024. The course will be focused on PH Impedance, Oesophageal and Anorectal Manometry, EGG and EndoFLIP. Participants can choose to attend one or both days.
